Αποτελέσματα Αναζήτησης
In addition to typical respiratory symptoms such as fever, cough, and dyspnea, a large percentage of COVID-19 patients experience gastrointestinal (GI) complaints, with the most common symptoms being diarrhea, nausea, vomiting, and abdominal discomfort.
24 Φεβ 2020 · In fact, the first reported patient with coronavirus disease 2019 (COVID-19) in the US reported gastrointestinal (GI) symptoms of loose bowel movements and abdominal discomfort. 12 The patient’s stool and respiratory specimens were found to be positive for SARS-CoV-2 by real-time reverse transcription–polymerase chain reaction (RT-PCR). 12 ...
We identified COVID-19 patients with mild disease and one or more digestive symptoms (diarrhea, nausea, and vomiting), with or without respiratory symptoms, and compared them with a group presenting solely with respiratory symptoms.
6 Ιουν 2021 · In brief, to understand more accurately the true prevalence of digestive symptoms in COVID-19 patients, it is critical to systematically collect the following information: Onset of nausea and vomiting, diarrhea, abdominal pain; duration of symptoms; and documentation of whether and how long GI symptoms precede the upper respiratory infection ...
17 Φεβ 2021 · Patients may present with GI symptoms alone or with respiratory symptoms. Healthcare providers should be aware of the GI manifestations of COVID-19 and perform SARS-CoV-2 testing in patients presenting with digestive changes, especially in those with respiratory symptoms.
22 Απρ 2022 · Gastrointestinal symptoms and SARS-CoV-2 RNA shedding in feces point to the gastrointestinal tract as a possible site of infection in COVID-19. Researchers from Stanford University measured the dynamics of fecal viral RNA in patients with mild to moderate COVID-19 followed for 10 months post-diagnosis.
Coronaviruses, including SARS-CoV-2, are strongly associated with respiratory symptoms during infection, but gastrointestinal symptoms, such as diarrhea, vomiting, nausea, and abdominal pain, have been identified in subsets of COVID-19 patients.
